Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The GI-4000 therapeutic vaccine or placebo will be injected under the skin of post-resection, non-metastatic pancreas cancer patients. Patients will be monitored for recurrence as well as safety, and immune responses related to the injections.
Epistemonikos ID: c4418256e79c663ac44aedd80415d96d0e994ace
First added on: May 04, 2024